Howard Horn is the Chief Financial Officer and Executive Vice President of Corporate Strategy at Ultragenyx Pharmaceutical. He stepped into this role on October 9, 2023, bringing over six years of significant experience in the biotechnology sector. Previously, he served...

Howard Horn is the Chief Financial Officer and Executive Vice President of Corporate Strategy at Ultragenyx Pharmaceutical. He stepped into this role on October 9, 2023, bringing over six years of significant experience in the biotechnology sector. Previously, he served as the Executive Vice President and Chief Financial Officer for Vir Biotechnology, where he played a key role in financial strategy from 2017 to 2023. Horn has a solid educational foundation, holding a Bachelor's degree in Economics from Princeton University and an MBA from the Wharton School of the University of Pennsylvania, both prestigious institutions that set him on a successful career path. At Ultragenyx, he received a base salary of $590,000 with a sign-on bonus of $60,000 and a sizable equity grant of $6 million, showing the company's investment in his leadership. He's known for his deep expertise in finance, particularly within the biotech industry. Interested in how business decisions can impact healthcare, Horn is not just about numbers but also understands the broader implications of corporate strategy in medicine. His journey reflects a blend of financial acumen and strategic insight that aligns with Ultragenyx's mission.